Ubs Group Ag Nkarta, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Nkarta, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 20,675 shares of NKTX stock, worth $38,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,675

Previous 215,505 90.41%

Holding current value

$38,662

Previous $357,000 88.24%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$1.67 - $2.37 $325,366 - $461,747	-194,830 Reduced 90.41%	20,675 $42,000
Q2 2025 Aug 14, 2025	SELL	$1.51 - $2.22 $37,676 - $55,391	-24,951 Reduced 10.38%	215,505 $357,000
Q1 2025 May 13, 2025	SELL	$1.37 - $2.53 $56,460 - $104,266	-41,212 Reduced 14.63%	240,456 $442,000
Q4 2024 Feb 14, 2025	BUY	$2.17 - $4.34 $408,615 - $817,230	188,302 Added 201.68%	281,668 $701,000
Q3 2024 Nov 14, 2024	BUY	$4.52 - $8.0 $92,492 - $163,704	20,463 Added 28.07%	93,366 $422,000

Q2 2024 Aug 13, 2024	BUY	$5.27 - $10.82 $218,114 - $447,818	41,388 Added 131.33%	72,903 $430,000
Q1 2024 May 13, 2024	SELL	$5.59 - $15.71 $15,478 - $43,500	-2,769 Reduced 8.08%	31,515 $340,000
Q4 2023 Feb 09, 2024	BUY	$1.31 - $6.6 $26,171 - $131,854	19,978 Added 139.65%	34,284 $226,000
Q3 2023 Nov 09, 2023	SELL	$1.39 - $2.29 $6,027 - $9,929	-4,336 Reduced 23.26%	14,306 $19,000
Q2 2023 Aug 11, 2023	SELL	$2.19 - $5.17 $17,382 - $41,034	-7,937 Reduced 29.86%	18,642 $40,000
Q1 2023 May 12, 2023	SELL	$3.37 - $6.3 $795 - $1,486	-236 Reduced 0.88%	26,579 $94,000
Q4 2022 Feb 08, 2023	SELL	$5.14 - $14.35 $11,292 - $31,526	-2,197 Reduced 7.57%	26,815 $160,000
Q3 2022 Nov 10, 2022	SELL	$12.27 - $18.39 $246,909 - $370,061	-20,123 Reduced 40.95%	29,012 $381,000
Q2 2022 Aug 10, 2022	BUY	$7.77 - $19.44 $368,601 - $922,214	47,439 Added 2797.11%	49,135 $605,000
Q1 2022 May 16, 2022	SELL	$8.66 - $14.99 $36,830 - $63,752	-4,253 Reduced 71.49%	1,696 $19,000
Q4 2021 Feb 14, 2022	SELL	$12.79 - $26.88 $587,521 - $1.23 Million	-45,936 Reduced 88.53%	5,949 $92,000
Q3 2021 Nov 15, 2021	BUY	$26.67 - $38.76 $1.15 Million - $1.67 Million	43,203 Added 497.62%	51,885 $1.44 Million
Q2 2021 Aug 13, 2021	SELL	$23.94 - $36.68 $466,806 - $715,223	-19,499 Reduced 69.19%	8,682 $275,000
Q1 2021 May 12, 2021	BUY	$31.33 - $59.61 $881,814 - $1.68 Million	28,146 Added 80417.14%	28,181 $927,000
Q4 2020 Feb 11, 2021	SELL	$27.03 - $75.62 $28,435 - $79,552	-1,052 Reduced 96.78%	35 $2,000
Q3 2020 Nov 12, 2020	BUY	$23.52 - $47.9 $25,566 - $52,067	1,087 New	1,087 $33,000

Others Institutions Holding NKTX

# of Institutions

127

Shares Held

58.1M

Call Options Held

Put Options Held

58.3K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $91M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account